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Abstract
Introduction: The aim of our study is to compare new Greiner tubes containing granulated citrate buffer with the Terumo ones and to verify if they 
are suitable for glucose stabilization after prolonged storage.
Materials and methods: In Study 1, blood was collected in two Terumo and two Greiner tubes from 40 healthy volunteers. Samples were stored at 
room temperature (RT) for 1 and 2 hours, respectively. Comparison was made by Deming regression. In Study 2, glucose was measured in a reference 
tube (N = 50), according to the ADA-NACB guidelines and in aliquots of Greiner samples maintained un-centrifuged at RT for 1, 2, 4 (N = 50) and 24, 
48, 72 hours (N = 35). 
Results: There were insignificant mixed biases between the Terumo and Greiner tubes. Compared to reference (5.3 mmol/L), glucose concentration 
in the new tubes was 5.4 (P < 0.05), 5.4 (P < 0.05), 5.3 (P = 0.265), 5.2 (P = 0.156), 5.3 (P < 0.05) and 5.2 (P < 0.05) mmol/L after 1, 2, 4, 24, 48 and 
72 hours at RT, respectively. There was no biological difference between any of the time points up to 48 h (bias < ± 1.95%).
Conclusions: The study shows that the new tubes perform equally well as the Terumo ones and ensure glucose stabilization up to 48 h as well as 
permit to create a link between the previous studies demonstrating the clinical utility of granulated citrate buffer and the future ones.
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The measurement of plasma glucose plays a cen-
tral role in the diagnosis of diabetes mellitus (DM) 
and an accurate glucose determination is manda-
tory.
Glucose concentrations are highly dependent on 
the pre-analytical phase due to ex-vivo glycolysis 
in the collected blood that may represent an im-
portant source of bias. Because the blood collec-
tion sites are often far from laboratories, samples 
processing can be delayed several hours affecting 
the accurate measurement, if samples are not col-
lected in proper tubes or handled according to the 
American Diabetes Association (ADA) and the Na-
tional Academy of Clinical Biochemistry (NACB) 
guidelines (1). To obtain accurate glucose measure-
ments, the ADA-NACB recommends placing the 
sample tube in ice-water slurry immediately after 
the blood draw and separating plasma from the 
cells within 30 minutes, or using a rapid glycolysis 
inhibitor, such as citrate buffer (1).
Since the first published evidence of Gambino et al. 
in 2009 using Terumo tubes, different papers have 
been published showing that citrate buffer and so-
dium fluoride containing tubes in granular and liq-
uid form are an effective glycolysis inhibitor permit-
ting an accurate glucose determination (2-4).
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Based on the evidences from studies on Terumo 
tubes, experts from ADA and NACB inserted the 
recommendation of using citrate buffer contain-
ing tubes to prevent in vitro glycolysis and to en-
sure accurate glucose determinations advising 
against the use of tubes containing only sodium-
fluoride (NaF).
Terumo tubes were discontinued worldwide and 
the patent of VenosafeTM Glycaemia FC-Mix (Teru-
mo) was taken over by Greiner Bio-One with Vacu-
ette® FC-Mix NaF-EDTA-citrate tube (Greiner).
To verify if the new Greiner tubes are equivalent to 
the Terumo ones and to understand if these per-
mit prolonged glucose in vitro stabilization up to 




This study consists of two parts: two groups of 
healthy volunteers were recruited from July 2016 
to February 2017 in two centres (Brescia and Vice-
nza) in northern Italy. This study was conducted 
according to the principles of the revised Helsinki 
Declaration and all participants signed an in-
formed consent form. Blood samples were collect-
ed by two different skilled phlebotomists, from 
the antecubital vein using 21-gauge needles into:
•	 Venosafe Glycaemia tube (ref. VF-053SFC32, 
Terumo, Rome, Italy), 3 mL draw,
•	 Vacuette FC-Mix NaF-EDTA-citrate tube (con-
taining a mixture of Na2EDTA, NaF, citric acid 
and Na citrate) (ref. 454513, Greiner Bio-One Ita-
lia, Cassina de Pecchi, Italy), 3 mL draw,
•	 S-Monovette Lithium-heparin tube (ref. 
04.1939.001, Sarstedt, Verona, Italy), 4.9 mL 
draw, in Brescia,
•	 BD Vacutainer Lithium-heparin tube (ref. 
368884, Becton Dickinson Italia, Milano, Italy), 4 
mL draw, in Vicenza.
In the first study, 40 healthy volunteers (30 females 
and 10 males; aged 50 years, range: 24 – 70) were 
subjected to phlebotomy. Two Terumo and two 
Greiner tubes were collected and maintained at 
room temperature (20 - 25°C) for 1 and 2 hours (h) 
before centrifugation at 2500xg for 15 min at 20°C 
using Sorvall RG3 centrifuge (Thermo Fisher Scien-
tific, Monza, Italy) in the Brescia laboratory and 
Haereus Megafuge 1.0R centrifuge (Thermo Fisher 
Scientific, Monza, Italy) in the Vicenza laboratory, 
respectively. Plasma samples were maintained at 
4°C until analysis, 2.5 hours from blood drawing.
In the 50 participants (35 females and 15 males: 
aged 45 years, range: 20 - 62) of the second study, 
blood was collected in one lithium-heparin tube 
and one (for the stability up to 4 h, N = 50) or two 
(for the stability up to 72 h, N = 35) Greiner tubes 
for each volunteer. According to the NACB-ADA 
guidelines, the reference glucose was measured in 
lithium-heparin (Li-Hep) tubes placed immediate-
ly after the blood draw in an ice-water slurry for a 
maximum of 15 minutes, centrifuged at 2000xg at 
4°C for 15 min using J6-MI centrifuge (Beckman 
Coulter, Roma, Italy) and the plasma separated 
from the cells.
Immediately after venepuncture, blood in each 
Greiner tube was aliquoted in three different micro-
tube (ref. 72.706, Sarstedt, Verona, Italy) and vials 
were placed on a shaker (Tecno-lab, Brescia, Italy) at 
RT before centrifugation at 2500xg, 15 minutes at 
20°C after 1, 2, 4, 24, 48, and 72 h, respectively. Plas-
ma samples were maintained refrigerated at 4 °C 
until analysis, 72 h from the blood drawing.
In Study 1 and Study 2, duplicate glucose meas-
urements were performed in each sample tube of 
the same participant in a single analytical run, to 
avoid inter-assay variability, on Dimension Vista 
1500 analysers (Siemens Healthcare Diagnostics, 
Milan, Italy) using the hexokinase method.
Glucose internal quality control (IQC) was evaluat-
ed by Liquid Assayed Multiqual® (Biorad Laborato-
ries, Milano, Italy; level 1: 3.3 mmol/L and level 3: 
19.6 mmol/L; TEa: < ± 5.5%) in the Brescia labora-
tory and by the ACQ chemistry control (Astra For-
medic, Milano, Italy; level 1: 3.1 mmol/L and level 2: 
7.2 mmol/L; TEa: < ± 5.5%) in the Vicenza labora-
tory. The inter-assay CVs were 2.1% in Brescia and 
2.8% in Vicenza.
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Statistical analysis
In the first study, method comparison was made 
by Deming regression and by Bland-Altman analy-
sis. In the second study, a box-and-whisker plot 
with dots was used to show glucose concentration 
in all used tubes. The D’agostino Pearson Test was 
used to test the normality of all the data sets. The 
results were presented as median and interquar-
tile range (IQR), because not all data were normally 
distributed. The differences between glucose con-
centrations in different groups were tested using 
paired Wilcoxon Rank Sum test. Biases from the 
reference glucose were calculated according to 
the formula: (GluTx / Gluref) x 100 - 100, where the 
GluTx represents the mean of duplicate glucose of 
tubes maintained at RT for x hours and Gluref rep-
resents the mean of duplicate glucose in the refer-
ence tube, according to the NACB-ADA guidelines. 
Median biases were evaluated according to the bi-
ological variation data (desirable glucose bias < 
± 1.95). All the statistical analysis was performed 
using the MedCalc statistical software version 17.4 
(MedCalc Software, Ostend, Belgium). The values 
of P < 0.05 were considered statistically significant.
Results
In the first study, the median glucose concentra-
tions from 40 participants were 5.5 mmol/L (IQR: 
5.1 – 6.0) in Terumo tubes and 5.4 mmol/L (IQR: 5.1 
– 5.9) in Greiner tubes maintained 1 h at RT after 
the blood draw, P = 0.143. Glucose concentrations 
were 5.4 mmol/L (IQR: 5.2 – 5.9) in Terumo and 5.4 
mmol/L (IQR: 5.1 – 5.8) in Greiner tubes maintained 
2 h at RT, P = 0.088.
Comparison between glucose concentrations in 
Terumo and Greiner tubes after 1 and 2 h at RT are 
shown as Deming regression in Figure 1, and as 
Bland Altman plots for differences in Figure 2.
Median glucose concentrations in reference and in 
Greiner tubes up to 72 h and their relative bias to 
reference glucose are presented in Table 1. In Fig-
ure 3, a box-and-whisker plot with dots is present-
ed to show the glucose concentration reduction in 
all the used tubes.
In Greiner tubes, the observed bias does not ex-
ceed the desirable analytical goal, according to 
the biological variability criteria even with a delay 
of 48 h.
Figure 1. Comparison by Deming regression between glucose 
in Terumo (x- axis) and Greiner tubes (y-axis). (A) 1 hour storage 
at room temperature. (B) 2 hours storage at room temperature. 
The regression line equation is presented as Y = A (95% CI) x + B 
(95% CI). 95% CI – 95% confidence intervals. A – regression line 
slope. B – regression line intercept. Solid line – regression line. 


















































y = 1.03 (0.96 to 1.09) x + 0.20 (-0.56 to 0.16)
A
B
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Figure 2. Differences in glucose concentrations between Teru-
mo and Greiner tubes by Bland-Altman plots. (A) 1 hour storage 
and (B) 2 hours storage at room temperature (RT) from blood 
drawing. Solid line – mean difference. Dashed lines - limits of 
agreement ± 1.96 standard deviation (SD). Dotted lines - zero 
bias.








































































Figure 3. Box-and-whisker plots of glucose concentrations 
in reference samples (grey points) and Greiner tubes (black 
points) maintained at room temperature (RT) at different time-
points from the blood drawing.
Reference glucose concentrations were obtained from lithium-
heparin tubes placed in an ice-water slurry and centrifuged 
within 30 minutes, according to the NACB-ADA guidelines.
Sample tube Glucose, mmol/L P-value vs reference Bias, %
Reference ADA-NACB, N = 50 5.3 (5.0 – 5.7) - -
Greiner, 1 h RT, N = 50 5.4 (5.1 – 5.8) 0.002 1.62% (0.80 – 2.44)
Greiner, 2 h RT, N = 50 5.4 (5.0 – 5.8) 0.003 1.48% (0.58 – 2.38)
Greiner, 4 h RT, N = 50 5.3 (5.1 – 5.7) 0.265 0.60% (- 0.15 – 1.35)
Greiner, 24 h RT, N = 35 5.3 (4.9 – 5.5) 0.156 - 0.36% (- 1.52 – 0.80)
Greiner, 48 h RT, N = 35 5.3 (4.9 – 5.4) 0.001 - 1.88% (- 3.39 – (- 0.36))
Greiner, 72 h RT, N = 35 5.2 (5.0 – 5.3)  < 0.001 - 2.73% (- 4.74 – (- 0.73))
Glucose concentrations are presented as median and interquartile range (IQR). P values < 0.05 are considered statistically 
significant. Bias from the reference tube is presented as mean (95%CI). Biases exceeding the desirable goal according to biological 
variation criteria (< ± 1.95%) are bolded. ADA - American Diabetes Association. NACB - National Academy of Clinical Biochemistry. 
RT - room temperature.








































Here, we present the first study demonstrating 
that the glucose determinations in the only cur-
rently available granulated citrate tube, that is FC-
Mix from Greiner Bio-One, perform equally well 
than those in the old Terumo ones in samples from 
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healthy subjects maintained at RT for 1 and 2 h af-
ter the blood drawing. Terumo tubes that are no 
longer available worldwide, are previously validat-
ed in different studies (2,3) and are used in clinical 
laboratories for an accurate glucose determina-
tion.
In the second part of our study, we demonstrate 
for the first time that the glucose concentrations 
measured in the new Greiner tube are similar to 
those under the optimal pre-analytical conditions, 
according to the ADA-NACB guidelines, if main-
tained at RT up to 48 h.
In a recent study by Van der Hagen et al., a correla-
tion between glucose concentrations in the Grein-
er tubes and the WHO recommended procedure 
was shown (5). No differences in glucose concen-
trations were found when samples are maintained 
at RT after the blood drawing for 8 h and when 
samples were maintained at 37°C for 24 h, even if 
in a lower number (N = 22) of healthy volunteers; 
the reference samples were immediately placed in 
an ice-water slurry and centrifuged within 5 min 
(5). In a study from Dimeski et al., glucose in the 
Greiner tubes was stable up to 4 h when kept at 
RT, at 2 - 8°C and at 37°C in 2 healthy volunteers, if 
compared to sample centrifuged within 10 min (6). 
In the same study, no significant biases of + 0.4% 
and + 1.0% were found after 2 h and 4 h at RT in 
glucose determined in the Greiner tubes centri-
fuged within 10 min from blood drawing when 
compared to the reference Li-Hep tube (N = 41) 
centrifuged within 10 min from blood drawing 
and immediately analysed (6).
A higher bias after 2 h and 4 h (+ 1.48% and + 
0.60%, respectively) was found in our study. This 
may be due to the different protocols used; we 
maintained samples on a shaker during storage 
while Dimeski et al. maintained previously centri-
fuged samples at RT up to 4 h creating a possibly 
better pre-analytical condition, even if the refer-
ence glucose wasn’t according to the NACB-ADA 
guidelines.
The use of glycolysis inhibitor in granular form has 
a pre-analytical advantage by eliminating any dilu-
tion effects, which could occur due to the insuffi-
cient tube filling using liquid additive. 
Previous Glucomedics tubes from the Greiner Bio-
One containing a liquid mixture of NaF-EDTA-cit-
rate showed some problems related to which cor-
rection factor to use, and Van der Hagen et al. pos-
tulated that an effective correction factor should 
be established on hematocrit value (7,8). Glucose 
concentrations in these tubes were stable at RT up 
to 180 minutes as demonstrated by Juricic et al. (9).
In a study by our group, we demonstrated that cit-
rate mixture in liquid form in the GlucoEXACT 
tubes from Sarstedt gave accurate glucose stabili-
zation up to 4 h at RT using the correction factor 
established from the manufacturer (4).
Winter et al. demonstrated a long-term stability of 
glucose up to 96 h at RT with a continuous shak-
ing, when Terumo tubes were used (10). In this 
study, a lower stability was found for the same. 
This difference could be explained by a different 
treatment of blood samples. In our study, different 
samples were centrifuged at various time-points, 
while in the study from Winter et al. samples were 
re-centrifuged at 24, 48, 72 and 96 h and after-
word re-suspended until the next time point.
Our study has few limitations: we didn’t compare 
Terumo and Greiner tubes immediately after the 
blood drawing, the evaluation of stability after 24, 
48 and 72 h was conducted only in 35 samples, 
and finally, the study was based on healthy volun-
teers, so further studies are needed to investigate 
the biases near the cut-off values that are impor-
tant for the DM diagnosis.
This study shows for the first time that the new 
tubes perform equally well as the Terumo ones 
and stabilizes the glucose up to 48 h in samples 
maintained at RT. Furthermore, it will permit to 
create a link between previous studies demon-
strating the clinical utility of citrate buffer for good 
in-vitro glucose stabilization, as stated in the ADA-
NACB guidelines and the future ones. Only reliable 
results of glucose, such as the ones from the new 
granular NAF-EDTA-citrate mixture could be effec-
tive in diabetes management.
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